Reducing Risk of Severe Liver Injury in Patients Treated With Isoniazid

被引：3

作者：

Andrade, Raul J. ^{[1
,2
]}

机构：

[1] Univ Malaga, Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga, Unidad Gest Clin Enfermedades Digest,Dept Med, E-29071 Malaga, Spain

[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain

来源：

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 13卷 / 09期

关键词：

LATENT TUBERCULOSIS INFECTION; UNITED-STATES; NAT2; GENOTYPE; FAILURE; HEPATITIS; THERAPY;

D O I：

10.1016/j.cgh.2015.04.021

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1683 / 1685

页数：3

共 16 条

[1]

Pharmacogenomics in Drug Induced Liver Injury [J].

Andrade, Raul J. ;

Agundez, Jose A. G. ;

Isabel Lucena, M. ;

Martinez, Carmen ;

Cueto, Raquel ;

Garcia-Martin, Elena .

CURRENT DRUG METABOLISM, 2009, 10 (09) :956-970

[2]

Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].

Andrade, RJ ;

Lucena, MI ;

Fernández, MC ;

Pelaez, G ;

Pachkoria, K ;

García-Ruiz, E ;

García-Munoz, B ;

González-Grande, R ;

Pizarro, A ;

Durán, JA ;

Jiménez, M ;

Rodrigo, L ;

Romero-Gomez, M ;

Navarro, JM ;

Planas, R ;

Costa, J ;

Borras, A ;

Soler, A ;

Salmerón, J ;

Martin-Vivaldi, R .

GASTROENTEROLOGY, 2005, 129 (02) :512-521

[3]

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy [J].

Azuma, Junichi ;

Ohno, Masako ;

Kubota, Ryuji ;

Yokota, Soichiro ;

Nagai, Takayuki ;

Tsuyuguchi, Kazunari ;

Okuda, Yasuhisa ;

Takashima, Tetsuya ;

Kamimura, Sayaka ;

Fujio, Yasushi ;

Kawase, Ichiro .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) :1091-1101

[4]

Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis [J].

Cai, Yu ;

Yi, JiaYong ;

Zhou, ChaoHui ;

Shen, XiZhong .

PLOS ONE, 2012, 7 (10)

[5]

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States [J].

Chalasani, Naga ;

Fontana, Robert J. ;

Bonkovsky, Herbert L. ;

Watkins, Paul B. ;

Davern, Timothy ;

Serrano, Jose ;

Yang, Hongqiu ;

Rochon, James .

GASTROENTEROLOGY, 2008, 135 (06) :1924-1934

[6]

Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs [J].

Devarbhavi, Harshad ;

Andrade, Raul J. .

SEMINARS IN LIVER DISEASE, 2014, 34 (02) :145-161

[7]

Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset [J].

Fontana, Robert J. ;

Hayashi, Paul H. ;

Gu, Jiezhun ;

Reddy, K. Rajender ;

Barnhart, Huiman ;

Watkins, Paul B. ;

Serrano, Jose ;

Lee, William M. ;

Chalasani, Naga ;

Stolz, Andrew ;

Davern, Timothy ;

Talwakar, Jayant A. .

GASTROENTEROLOGY, 2014, 147 (01) :96-U189

[8]

ISONIAZID-ASSOCIATED HEPATITIS - REPORT OF AN OUTBREAK [J].

GARIBALDI, RA ;

FEREBEE, SH ;

GREGG, MB ;

DRUSIN, RE .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1972, 106 (03) :357-+

[9]

Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity [J].

Hayashi, Paul H. ;

Fontana, Robert J. ;

Chalasani, Naga P. ;

Stolz, Andrew A. ;

Talwalkar, Jay A. ;

Navarro, Victor J. ;

Lee, William M. ;

Davern, Timothy J. ;

Kleiner, David E. ;

Gu, Jiezhun ;

Hoofnagle, Jay H. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (09) :1676-+

[10]

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis [J].

Huang, YS ;

Chern, HD ;

Su, WJ ;

Wu, JC ;

Lai, SL ;

Yang, SY ;

Chang, FY ;

Lee, SD .

HEPATOLOGY, 2002, 35 (04) :883-889

← 1 2 →